b'\n_START_ARTICLE_\nFavipiraviir\n_START_SECTION_\nNimetused ja t\xc3\xa4hised\n_START_PARAGRAPH_\nIUPAC nimetus: 5-fluoro-2-oxo-1H-pyrazine-3-carboxamide._NEWLINE_CAS-i registreerimisnumber on 259793-96-9. PubChemi number on\xc2\xa0: CID 492405._NEWLINE_Farmakoterapeutiline r\xc3\xbchm\xc2\xa0: m\xc3\xa4\xc3\xa4ratlemata, ATC-kood on m\xc3\xa4\xc3\xa4ratlemata (ravim on registreerimata)._NEWLINE_S\xc3\xbcnon\xc3\xbc\xc3\xbcmid: 259793-96-9, T-705, 6-fluoro-3-oxo-3,4-dihydropyrazine-2-carboxamide, 6-FLUORO-3-HYDROXYPYRAZINE-2-CARBOXAMIDE, UNII-EW5GL2X7E0, _NEWLINE_AC1LAOUM, Favipiravir (JAN/INN), CHEMBL221722, _NEWLINE_2-Pyrazinecarboxamide, 6-fluoro-3-hydroxy-, AKOS005166863, T705, 5-fluoro-2-oxo-1H-pyrazine-3-carboxamide, D09537, AIDS121660, CID492405, _NEWLINE_Favipiravir; T-705, Favipiravir [USAN:INN], SureCN587913, SureCN6378032, EW5GL2X7E0, cc-562, CTK8C4699, MolPort-001-801-281, MolPort-004-768-381, BCPP000056, ANW-72832, DCL000291, QC-771, RW3035, AKOS015995178, CID4424075, CS-0612, PB25591, RP22092, 6-fluoro-3-hydroxy-2-pyrazinecarboxamide, AK-67681, BD208417, BR-67681, HY-14768, _NEWLINE_6-fluoro-3-oxo-4H-pyrazine-2-carboxamide, AM20080851, FT-0686297, T 705, _NEWLINE_A25520, S-7880, T 705, CAS;259793-96-9, 2-Pyrazinecarboxamide, 6-fluoro-3,4-dihydro-3-oxo-, 3-bromo-5-hydroxy-4-methyl-2,6-dinitro-benzoic Acid, _NEWLINE_T 705|259793-96-9|T-705|T705.\n_START_SECTION_\nN\xc3\xa4idustused\n_START_PARAGRAPH_\nRavim on m\xc3\xb5eldud A, B, C  gripiviiruste, L\xc3\xa4\xc3\xa4ne-Niiluse viiruse, kollapalaviku viiruse, mitmete flavi-, arena-, bunya- ja alfaviiruste poolt p\xc3\xb5hjustatud nakkuste raviks.\n_START_SECTION_\nAvastamine\n_START_PARAGRAPH_\nFavipiraviiri avastas 1998. aastal Yousuke Furuta (tootja Toyama Chemical)._NEWLINE_\xc3\x95igused ravimile on Fujifilmil.'